Have you or a loved one taken Invokana or another SGLT2 inhibitor?
The manufacturer of Invokana failed to warn patients and physicians
of the increased risks when taking the medication to treat Type 2 Diabetes.
What are SGLT2 Inhibitor Drugs?
Invokana, Invokamet, Farxiga, Xigduo XR, Jardiance and Glyxambi are all classified as SGLT2 inhibitor drugs. These drugs are used to lower blood sugar and improve glycemic control by helping the kidneys remove glucose from the bloodstream. Without an SGLT2, your kidney tries to re-absorb glucose and keep it in the bloodstream. They are most commonly prescribed to treat Type 2 diabetes.
Major side effects caused by SGLT2 Inhibitors:
Kidney damage or failure
Amputation, Ketoacidosis and Kidney Problem Lawsuit Information
The FDA has issued warnings about potential serious side effects from taking SGLT2 inhibitors, including an increased risk of amputation, ketoacidosis and kidney problems. Individuals who have suffered injuries from Invokana are filling lawsuits against Johnson & Johnson and Janssen Pharmaceuticals, the manufactures of Invokana and other SGTL2 inhibitor drugs. These manufactures failed to properly test the medication and warn users of the increased risks.
If you or a loved one has suffered any of these conditions after using these products, you may be eligible for a cash settlement.